NRP2
(Preusmjereno sa stranice VEGF165R2)
edit |
Neuropilin 2 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Prikaz baziran na PDB 2QQJ. | |||||||||||
Dostupne strukture | |||||||||||
2QQJ, 2QQK, 2QQL, 2QQO | |||||||||||
Identifikatori | |||||||||||
Simboli | NRP2; NP2; NPN2; PRO2714; VEGF165R2 | ||||||||||
Vanjski ID | OMIM: 602070 MGI: 1100492 HomoloGene: 2875 GeneCards: NRP2 Gene | ||||||||||
| |||||||||||
Pregled RNK izražavanja | |||||||||||
podaci | |||||||||||
Ortolozi | |||||||||||
Vrsta | Čovek | Miš | |||||||||
Entrez | 8828 | 18187 | |||||||||
Ensembl | ENSG00000118257 | ENSMUSG00000025969 | |||||||||
UniProt | O60462 | O35375 | |||||||||
RefSeq (mRNA) | NM_003872.2 | NM_001077403.1 | |||||||||
RefSeq (protein) | NP_003863.2 | NP_001070871.1 | |||||||||
Lokacija (UCSC) | Chr 2: 206.55 - 206.66 Mb | Chr 1: 62.7 - 62.82 Mb | |||||||||
PubMed pretraga | [1] | [2] |
Neuropilin-2 je protein koji je kod ljudi kodiran NRP2 genom.[1][2]
Ovaj protein je član neuropilinske familije receptora. On je transmembranski protein koji se vezuje za SEMA3C protein (sema domen, imunoglobulinski domen (Ig), kratki bazni domen) i SEMA3F protein. On formira interakciju sa vaskularnim endotelnim faktorom rasta (VEGF). Ovaj protein učestvuje u kardiovaskularnom razvoju, navođenu aksona, i tumorigenezi. Višestruke transkriptne varijante koje kodiraju različite izoforme su poznate.[3]
Reference[uredi | uredi kod]
- ↑ Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (Apr 1998). „Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor”. Cell 92 (6): 735–45. DOI:10.1016/S0092-8674(00)81402-6. PMID 9529250.
- ↑ Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M (Nov 1997). „Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III”. Neuron 19 (3): 547–59. DOI:10.1016/S0896-6273(00)80371-2. PMID 9331348.
- ↑ „Entrez Gene: NRP2 neuropilin 2”.
Literatura[uredi | uredi kod]
- Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999). „Vascular endothelial growth factor (VEGF) and its receptors.”. FASEB J. 13 (1): 9–22. PMID 9872925.
- Kolodkin AL, Levengood DV, Rowe EG, et al. (1997). „Neuropilin is a semaphorin III receptor.”. Cell 90 (4): 753–62. DOI:10.1016/S0092-8674(00)80535-8. PMID 9288754.
- Giger RJ, Urquhart ER, Gillespie SK, et al. (1999). „Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity.”. Neuron 21 (5): 1079–92. DOI:10.1016/S0896-6273(00)80625-X. PMID 9856463.
- Chen H, He Z, Bagri A, Tessier-Lavigne M (1999). „Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins.”. Neuron 21 (6): 1283–90. DOI:10.1016/S0896-6273(00)80648-0. PMID 9883722.
- Takahashi T, Nakamura F, Jin Z, et al. (1999). „Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors.”. Nat. Neurosci. 1 (6): 487–93. DOI:10.1038/2203. PMID 10196546.
- Rossignol M, Beggs AH, Pierce EA, Klagsbrun M (1999). „Human neuropilin-1 and neuropilin-2 map to 10p12 and 2q34, respectively.”. Genomics 57 (3): 459–60. DOI:10.1006/geno.1999.5790. PMID 10329017.
- Tamagnone L, Artigiani S, Chen H, et al. (1999). „Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.”. Cell 99 (1): 71–80. DOI:10.1016/S0092-8674(00)80063-X. PMID 10520995.
- Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G (2000). „Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected].”. J. Biol. Chem. 275 (24): 18040–5. DOI:10.1074/jbc.M909259199. PMID 10748121.
- Handa A, Tokunaga T, Tsuchida T, et al. (2000). „Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma.”. Int. J. Oncol. 17 (2): 291–5. PMID 10891538.
- Rossignol M, Gagnon ML, Klagsbrun M (2001). „Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms.”. Genomics 70 (2): 211–22. DOI:10.1006/geno.2000.6381. PMID 11112349.
- Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G (2001). „Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.”. J. Biol. Chem. 276 (22): 18688–94. DOI:10.1074/jbc.M006909200. PMID 11278319.
- Cohen T, Gluzman-Poltorak Z, Brodzky A, et al. (2001). „Neuroendocrine cells along the digestive tract express neuropilin-2.”. Biochem. Biophys. Res. Commun. 284 (2): 395–403. DOI:10.1006/bbrc.2001.4958. PMID 11394892.
- Herzog Y, Kalcheim C, Kahane N, et al. (2002). „Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins.”. Mech. Dev. 109 (1): 115–9. DOI:10.1016/S0925-4773(01)00518-4. PMID 11677062.
- Oh H, Takagi H, Otani A, et al. (2002). „Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.”. Proc. Natl. Acad. Sci. U.S.A. 99 (1): 383–8. DOI:10.1073/pnas.012074399. PMC 117569. PMID 11756651.
- Fakhari M, Pullirsch D, Abraham D, et al. (2002). „Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma.”. Cancer 94 (1): 258–63. DOI:10.1002/cncr.10177. PMID 11815985.
- Cohen T, Herzog Y, Brodzky A, et al. (2002). „Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.”. J. Pathol. 198 (1): 77–82. DOI:10.1002/path.1179. PMID 12210066.
- Kawakami T, Tokunaga T, Hatanaka H, et al. (2003). „Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.”. Cancer 95 (10): 2196–201. DOI:10.1002/cncr.10936. PMID 12412174.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). „Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. DOI:10.1073/pnas.242603899. PMC 139241. PMID 12477932.